BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernández MF, Reina-Pérez I, Astorga JM, Rodríguez-Carrillo A, Plaza-Díaz J, Fontana L. Breast Cancer and Its Relationship with the Microbiota. Int J Environ Res Public Health 2018;15:E1747. [PMID: 30110974 DOI: 10.3390/ijerph15081747] [Cited by in Crossref: 99] [Cited by in F6Publishing: 74] [Article Influence: 24.8] [Reference Citation Analysis]
Number Citing Articles
1 Teng NMY, Price CA, McKee AM, Hall LJ, Robinson SD. Exploring the impact of gut microbiota and diet on breast cancer risk and progression. Int J Cancer 2021;149:494-504. [PMID: 33521932 DOI: 10.1002/ijc.33496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Iraji A, Nouri A, Edraki N, Pirhadi S, Khoshneviszadeh M, Khoshneviszadeh M. One-pot synthesis of thioxo-tetrahydropyrimidine derivatives as potent β-glucuronidase inhibitor, biological evaluation, molecular docking and molecular dynamics studies. Bioorg Med Chem 2020;28:115359. [PMID: 32098709 DOI: 10.1016/j.bmc.2020.115359] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
3 Marwaha AK, Morris JA, Rigby RJ. Hypothesis: Bacterial induced inflammation disrupts the orderly progression of the stem cell hierarchy and has a role in the pathogenesis of breast cancer. Med Hypotheses 2020;136:109530. [PMID: 31862686 DOI: 10.1016/j.mehy.2019.109530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Martí JM. Recentrifuge: Robust comparative analysis and contamination removal for metagenomics. PLoS Comput Biol 2019;15:e1006967. [PMID: 30958827 DOI: 10.1371/journal.pcbi.1006967] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
5 Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M. Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers (Basel) 2019;11:E38. [PMID: 30609850 DOI: 10.3390/cancers11010038] [Cited by in Crossref: 143] [Cited by in F6Publishing: 129] [Article Influence: 47.7] [Reference Citation Analysis]
6 Liang J, Tang M, Wang L, Huang R, Fu A, Zhou J. Design and development of novel fasudil derivatives as potent antibreast cancer agent that improves intestinal flora and intestinal barrier function in rats. Chem Biol Drug Des 2021. [PMID: 34587363 DOI: 10.1111/cbdd.13963] [Reference Citation Analysis]
7 Zhang X, Yu L, Shi J, Li S, Yang S, Gao W, Yang S, Cheng M, Wang H, Guo Z, Geng C. Antibiotics modulate neoadjuvant therapy efficiency in patients with breast cancer: a pilot analysis. Sci Rep 2021;11:14024. [PMID: 34234229 DOI: 10.1038/s41598-021-93428-w] [Reference Citation Analysis]
8 Chen Q, He Z, Zhuo Y, Li S, Yang W, Hu L, Zhong H. Rubidium chloride modulated the fecal microbiota community in mice. BMC Microbiol 2021;21:46. [PMID: 33588762 DOI: 10.1186/s12866-021-02095-4] [Reference Citation Analysis]
9 Bodai BI, Nakata TE. Breast Cancer: Lifestyle, the Human Gut Microbiota/Microbiome, and Survivorship. Perm J 2020;24. [PMID: 32589577 DOI: 10.7812/TPP/19.129] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Sheikhhossein F, Imani H, Amini MR, Hosseini F, Shab-Bidar S. The association between adherence to MIND diet and risk of breast cancer: A case-control study. Int J Clin Pract 2021;75:e14780. [PMID: 34482608 DOI: 10.1111/ijcp.14780] [Reference Citation Analysis]
11 Pellegrini M, Ippolito M, Monge T, Violi R, Cappello P, Ferrocino I, Cocolin LS, De Francesco A, Bo S, Finocchiaro C. Gut microbiota composition after diet and probiotics in overweight breast cancer survivors: a randomized open-label pilot intervention trial. Nutrition 2020;74:110749. [PMID: 32234652 DOI: 10.1016/j.nut.2020.110749] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
12 Smith KS, Frugé AD, van der Pol W, Caston NE, Morrow CD, Demark-Wahnefried W, Carson TL. Gut microbial differences in breast and prostate cancer cases from two randomised controlled trials compared to matched cancer-free controls. Benef Microbes 2021;12:239-48. [PMID: 33789551 DOI: 10.3920/BM2020.0098] [Reference Citation Analysis]
13 Mirzaei R, Afaghi A, Babakhani S, Sohrabi MR, Hosseini-Fard SR, Babolhavaeji K, Khani Ali Akbari S, Yousefimashouf R, Karampoor S. Role of microbiota-derived short-chain fatty acids in cancer development and prevention. Biomed Pharmacother 2021;139:111619. [PMID: 33906079 DOI: 10.1016/j.biopha.2021.111619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Aarnoutse R, Hillege LE, Ziemons J, De Vos-Geelen J, de Boer M, Aerts EMER, Vriens BEPJ, van Riet Y, Vincent J, van de Wouw AJ, Le GN, Venema K, Rensen SS, Penders J, Smidt ML. Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls. Cancers (Basel) 2021;13:6200. [PMID: 34944820 DOI: 10.3390/cancers13246200] [Reference Citation Analysis]
15 Gupta I, Pedersen S, Vranic S, Al Moustafa AE. Implications of Gut Microbiota in Epithelial-Mesenchymal Transition and Cancer Progression: A Concise Review. Cancers (Basel) 2022;14:2964. [PMID: 35740629 DOI: 10.3390/cancers14122964] [Reference Citation Analysis]
16 Hossain F, Majumder S, David J, Bunnell BA, Miele L. Obesity Modulates the Gut Microbiome in Triple-Negative Breast Cancer. Nutrients 2021;13:3656. [PMID: 34684657 DOI: 10.3390/nu13103656] [Reference Citation Analysis]
17 Song X, Wei C, Li X. The Relationship Between Microbial Community and Breast Cancer. Front Cell Infect Microbiol 2022;12:849022. [DOI: 10.3389/fcimb.2022.849022] [Reference Citation Analysis]
18 Alizadehmohajer N, Shojaeifar S, Nedaeinia R, Esparvarinha M, Mohammadi F, Ferns GA, Ghayour-Mobarhan M, Manian M, Balouchi A. Association between the microbiota and women's cancers - Cause or consequences? Biomed Pharmacother 2020;127:110203. [PMID: 32559847 DOI: 10.1016/j.biopha.2020.110203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Huskey ALW, McNeely I, Merner ND. CEACAM Gene Family Mutations Associated With Inherited Breast Cancer Risk - A Comparative Oncology Approach to Discovery. Front Genet 2021;12:702889. [PMID: 34447411 DOI: 10.3389/fgene.2021.702889] [Reference Citation Analysis]
20 Quaglino E, Conti L, Cavallo F. Breast cancer stem cell antigens as targets for immunotherapy. Semin Immunol 2020;47:101386. [PMID: 31932198 DOI: 10.1016/j.smim.2020.101386] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
21 An Y, Zhang W, Liu T, Wang B, Cao H. The intratumoural microbiota in cancer: new insights from inside. Biochim Biophys Acta Rev Cancer 2021;1876:188626. [PMID: 34520804 DOI: 10.1016/j.bbcan.2021.188626] [Reference Citation Analysis]
22 Chen L, Zhou X, Wang Y, Wang D, Ke Y, Zeng X. Propionate and Butyrate Produced by Gut Microbiota after Probiotic Supplementation Attenuate Lung Metastasis of Melanoma Cells in Mice. Mol Nutr Food Res 2021;65:e2100096. [PMID: 34061433 DOI: 10.1002/mnfr.202100096] [Reference Citation Analysis]
23 Roomruangwong C, Carvalho AF, Geffard M, Maes M. The menstrual cycle may not be limited to the endometrium but also may impact gut permeability. Acta Neuropsychiatr 2019;31:294-304. [PMID: 31364524 DOI: 10.1017/neu.2019.30] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
24 Barroso-sousa R, Teles LT. Gut Microbiome and Breast Cancer in the Era of Cancer Immunotherapy. Curr Breast Cancer Rep 2019;11:272-6. [DOI: 10.1007/s12609-019-00346-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Ukrainets RV, Korneva YS, Dorosevich AE. [Abnormal gut microbiota-induced hypoestrogenemia as a possible risk factor for malignancy in endometrioid heterotopia]. Arkh Patol 2020;82:57-61. [PMID: 32307440 DOI: 10.17116/patol20208202157] [Reference Citation Analysis]
26 Al-Ansari MM, AlMalki RH, Dahabiyeh LA, Abdel Rahman AM. Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment. Metabolites 2021;11:758. [PMID: 34822416 DOI: 10.3390/metabo11110758] [Reference Citation Analysis]
27 Zafar H, Saier MH Jr. Gut Bacteroides species in health and disease. Gut Microbes 2021;13:1-20. [PMID: 33535896 DOI: 10.1080/19490976.2020.1848158] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 36.0] [Reference Citation Analysis]
28 Agurs-Collins T, Ross SA, Dunn BK. The Many Faces of Obesity and Its Influence on Breast Cancer Risk. Front Oncol 2019;9:765. [PMID: 31555578 DOI: 10.3389/fonc.2019.00765] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
29 Plaza-Díaz J, Solís-Urra P, Rodríguez-Rodríguez F, Olivares-Arancibia J, Navarro-Oliveros M, Abadía-Molina F, Álvarez-Mercado AI. The Gut Barrier, Intestinal Microbiota, and Liver Disease: Molecular Mechanisms and Strategies to Manage. Int J Mol Sci 2020;21:E8351. [PMID: 33171747 DOI: 10.3390/ijms21218351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
30 Doocey CM, Finn K, Murphy C, Guinane CM. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiol 2022;22. [DOI: 10.1186/s12866-022-02465-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Sehgal R, Bedi O, Trehanpati N. Role of Microbiota in Pathogenesis and Management of Viral Hepatitis.Front Cell Infect Microbiol. 2020;10:341. [PMID: 32850467 DOI: 10.3389/fcimb.2020.00341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
32 Samkari AA, Alsulami M, Bataweel L, Altaifi R, Altaifi A, Saleem AM, Farsi AH, Iskanderani O, Akeel NY, Malibary NH, Kadi MS, Fallatah E, Fakiha M, Shabkah AA, Trabulsi NH. Body Microbiota and Its Relationship With Benign and Malignant Breast Tumors: A Systematic Review. Cureus. [DOI: 10.7759/cureus.25473] [Reference Citation Analysis]
33 Mukherjee AG, Wanjari UR, Bradu P, Murali R, Kannampuzha S, Loganathan T, C GPD, Prakash B P A, Renu K, Dey A, Vellingiri B, Valsala Gopalakrishnan A. The crosstalk of the human microbiome in breast and colon cancer: A metabolomics analysis. Crit Rev Oncol Hematol 2022;176:103757. [PMID: 35809795 DOI: 10.1016/j.critrevonc.2022.103757] [Reference Citation Analysis]
34 Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, Alba E, Queipo-Ortuño MI. Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment. Cancers (Basel) 2020;12:E2465. [PMID: 32878124 DOI: 10.3390/cancers12092465] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
35 Parida S, Sharma D. The Microbiome-Estrogen Connection and Breast Cancer Risk. Cells 2019;8:E1642. [PMID: 31847455 DOI: 10.3390/cells8121642] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
36 Pons DG, Vilanova-llompart J, Gaya-bover A, Alorda-clara M, Oliver J, Roca P, Sastre-serra J. The phytoestrogen genistein affects inflammatory-related genes expression depending on the ERα/ERβ ratio in breast cancer cells. International Journal of Food Sciences and Nutrition 2019;70:941-9. [DOI: 10.1080/09637486.2019.1597025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
37 Zhang J, Lu R, Zhang Y, Matuszek Ż, Zhang W, Xia Y, Pan T, Sun J. tRNA Queuosine Modification Enzyme Modulates the Growth and Microbiome Recruitment to Breast Tumors. Cancers (Basel) 2020;12:E628. [PMID: 32182756 DOI: 10.3390/cancers12030628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Schreurs MPH, de Vos van Steenwijk PJ, Romano A, Dieleman S, Werner HMJ. How the Gut Microbiome Links to Menopause and Obesity, with Possible Implications for Endometrial Cancer Development. J Clin Med 2021;10:2916. [PMID: 34209916 DOI: 10.3390/jcm10132916] [Reference Citation Analysis]
39 Heymann CJF, Bard JM, Heymann MF, Heymann D, Bobin-Dubigeon C. The intratumoral microbiome: Characterization methods and functional impact. Cancer Lett 2021;522:63-79. [PMID: 34517085 DOI: 10.1016/j.canlet.2021.09.009] [Reference Citation Analysis]
40 Le Noci V, Bernardo G, Bianchi F, Tagliabue E, Sommariva M, Sfondrini L. Toll Like Receptors as Sensors of the Tumor Microbial Dysbiosis: Implications in Cancer Progression. Front Cell Dev Biol 2021;9:732192. [PMID: 34604233 DOI: 10.3389/fcell.2021.732192] [Reference Citation Analysis]
41 Raji Lahiji M, Najafi S, Janani L, Yazdani B, Razmpoosh E, Zarrati M. The effect of synbiotic on glycemic profile and sex hormones in overweight and obese breast cancer survivors following a weight-loss diet: A randomized, triple-blind, controlled trial. Clin Nutr 2021;40:394-403. [PMID: 32698957 DOI: 10.1016/j.clnu.2020.05.043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
42 Yin C, Noratto GD, Fan X, Chen Z, Yao F, Shi D, Gao H. The Impact of Mushroom Polysaccharides on Gut Microbiota and Its Beneficial Effects to Host: A Review. Carbohydrate Polymers 2020;250:116942. [DOI: 10.1016/j.carbpol.2020.116942] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
43 Sampsell K, Hao D, Reimer RA. The Gut Microbiota: A Potential Gateway to Improved Health Outcomes in Breast Cancer Treatment and Survivorship. Int J Mol Sci 2020;21:E9239. [PMID: 33287442 DOI: 10.3390/ijms21239239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 De Silva S, Tennekoon KH, Karunanayake EH. Interaction of Gut Microbiome and Host microRNAs with the Occurrence of Colorectal and Breast Cancer and Their Impact on Patient Immunity. Onco Targets Ther 2021;14:5115-29. [PMID: 34712050 DOI: 10.2147/OTT.S329383] [Reference Citation Analysis]
45 Bobin-Dubigeon C, Luu HT, Leuillet S, Lavergne SN, Carton T, Le Vacon F, Michel C, Nazih H, Bard JM. Faecal Microbiota Composition Varies between Patients with Breast Cancer and Healthy Women: A Comparative Case-Control Study. Nutrients 2021;13:2705. [PMID: 34444865 DOI: 10.3390/nu13082705] [Reference Citation Analysis]
46 Hadzega D, Minarik G, Karaba M, Kalavska K, Benca J, Ciernikova S, Sedlackova T, Nemcova P, Bohac M, Pindak D, Klucar L, Mego M. Uncovering Microbial Composition in Human Breast Cancer Primary Tumour Tissue Using Transcriptomic RNA-seq. Int J Mol Sci 2021;22:9058. [PMID: 34445764 DOI: 10.3390/ijms22169058] [Reference Citation Analysis]
47 Wang Y, Ku W, Liu C, Cheng Y, Chien C, Chang K, Huang C. Supplementation of Probiotic Butyricicoccus pullicaecorum Mediates Anticancer Effect on Bladder Urothelial Cells by Regulating Butyrate-Responsive Molecular Signatures. Diagnostics 2021;11:2270. [DOI: 10.3390/diagnostics11122270] [Reference Citation Analysis]
48 El-Sayed A, Aleya L, Kamel M. Microbiota and epigenetics: promising therapeutic approaches? Environ Sci Pollut Res Int 2021. [PMID: 34319520 DOI: 10.1007/s11356-021-15623-6] [Reference Citation Analysis]
49 Di Lorenzo A, Bolli E, Tarone L, Cavallo F, Conti L. Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota. Int J Mol Sci 2020;21:E9418. [PMID: 33321934 DOI: 10.3390/ijms21249418] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
50 Thomas R, Al-Khadairi G, Decock J. Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects. Front Oncol 2020;10:600573. [PMID: 33718107 DOI: 10.3389/fonc.2020.600573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
51 Rossi T, Vergara D, Fanini F, Maffia M, Bravaccini S, Pirini F. Microbiota-Derived Metabolites in Tumor Progression and Metastasis. Int J Mol Sci 2020;21:E5786. [PMID: 32806665 DOI: 10.3390/ijms21165786] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
52 Di Lorenzo A, Bolli E, Ruiu R, Ferrauto G, Di Gregorio E, Avalle L, Savino A, Poggio P, Merighi IF, Riccardo F, Brancaccio M, Quaglino E, Cavallo F, Conti L. Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. Oncoimmunology 2022;11:2086752. [PMID: 35756841 DOI: 10.1080/2162402X.2022.2086752] [Reference Citation Analysis]
53 Eyvazi S, Vostakolaei MA, Dilmaghani A, Borumandi O, Hejazi MS, Kahroba H, Tarhriz V. The oncogenic roles of bacterial infections in development of cancer. Microb Pathog 2020;141:104019. [PMID: 32006638 DOI: 10.1016/j.micpath.2020.104019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
54 Yoon HJ, Kim HN, Bang JI, Lim W, Moon BI, Paik NS, Kim BS, Kim HL. Physiologic intestinal 18F-FDG uptake is associated with alteration of gut microbiota and proinflammatory cytokine levels in breast cancer. Sci Rep 2019;9:18273. [PMID: 31797893 DOI: 10.1038/s41598-019-54680-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
55 Gal J, Bailleux C, Chardin D, Pourcher T, Gilhodes J, Jing L, Guigonis JM, Ferrero JM, Milano G, Mograbi B, Brest P, Chateau Y, Humbert O, Chamorey E. Comparison of unsupervised machine-learning methods to identify metabolomic signatures in patients with localized breast cancer. Comput Struct Biotechnol J 2020;18:1509-24. [PMID: 32637048 DOI: 10.1016/j.csbj.2020.05.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Morkūnas E, Skiecevičienė J, Kupčinskas J. The impact of modulating the gastrointestinal microbiota in cancer patients. Best Pract Res Clin Gastroenterol 2020;48-49:101700. [PMID: 33317795 DOI: 10.1016/j.bpg.2020.101700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
57 Jourquin J, Reffey SB, Jernigan C, Levy M, Zinser G, Sabelko K, Pietenpol J, Sledge G Jr. Susan G. Komen Big Data for Breast Cancer Initiative: How Patient Advocacy Organizations Can Facilitate Using Big Data to Improve Patient Outcomes. JCO Precis Oncol 2019;3:PO. [PMID: 32923852 DOI: 10.1200/PO.19.00184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
58 Kinlen LJ, Gilham C, Ray R, Thomas DB, Peto J. Cohabitation, infection and breast cancer risk. Int J Cancer 2021;148:1408-18. [PMID: 32984953 DOI: 10.1002/ijc.33319] [Reference Citation Analysis]
59 Kim R, Kin T. Reconsidering the Meaning of Curing Primary Breast Cancer as a Systemic Disease. Front Oncol 2021;11:639420. [PMID: 33816282 DOI: 10.3389/fonc.2021.639420] [Reference Citation Analysis]
60 Laborda-Illanes A, Sánchez-Alcoholado L, Boutriq S, Plaza-Andrades I, Peralta-Linero J, Alba E, González-González A, Queipo-Ortuño MI. A New Paradigm in the Relationship between Melatonin and Breast Cancer: Gut Microbiota Identified as a Potential Regulatory Agent. Cancers (Basel) 2021;13:3141. [PMID: 34201776 DOI: 10.3390/cancers13133141] [Reference Citation Analysis]
61 Quinn CM, Porwal M, Meagher NS, Hettiaratchi A, Power C, Jonnaggadala J, Mccullough S, Macmillan S, Tang K, Liauw W, Goldstein D, Zeps N, Crowe PJ. Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability. Biomark�Insights 2021;16:117727192110057. [DOI: 10.1177/11772719211005745] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
62 Sári Z, Mikó E, Kovács T, Boratkó A, Ujlaki G, Jankó L, Kiss B, Uray K, Bai P. Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress. Cancers (Basel) 2020;12:E2915. [PMID: 33050543 DOI: 10.3390/cancers12102915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
63 Buchta Rosean C, Feng TY, Azar FN, Rutkowski MR. Impact of the microbiome on cancer progression and response to anti-cancer therapies. Adv Cancer Res 2019;143:255-94. [PMID: 31202360 DOI: 10.1016/bs.acr.2019.03.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
64 Parida S, Sharma D. Microbial Alterations and Risk Factors of Breast Cancer: Connections and Mechanistic Insights. Cells 2020;9:E1091. [PMID: 32354130 DOI: 10.3390/cells9051091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
65 Chadha J, Nandi D, Atri Y, Nag A. Significance of human microbiome in breast cancer: Tale of an invisible and an invincible. Semin Cancer Biol 2021;70:112-27. [PMID: 32717337 DOI: 10.1016/j.semcancer.2020.07.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
66 Klann E, Williamson JM, Tagliamonte MS, Ukhanova M, Asirvatham JR, Chim H, Yaghjyan L, Mai V. Microbiota composition in bilateral healthy breast tissue and breast tumors. Cancer Causes Control 2020;31:1027-38. [PMID: 32844256 DOI: 10.1007/s10552-020-01338-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Sári Z, Mikó E, Kovács T, Jankó L, Csonka T, Lente G, Sebő É, Tóth J, Tóth D, Árkosy P, Boratkó A, Ujlaki G, Török M, Kovács I, Szabó J, Kiss B, Méhes G, Goedert JJ, Bai P. Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress. Cancers (Basel) 2020;12:E2411. [PMID: 32854297 DOI: 10.3390/cancers12092411] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
68 Meng Z, Ye Z, Zhu P, Zhu J, Fang S, Qiu T, Li Y, Meng L. New Developments and Opportunities of Microbiota in Treating Breast Cancers. Front Microbiol 2022;13:818793. [DOI: 10.3389/fmicb.2022.818793] [Reference Citation Analysis]
69 Haque S, Raina R, Afroze N, Hussain A, Alsulimani A, Singh V, Mishra BN, Kaul S, Kharwar RN. Microbial dysbiosis and epigenetics modulation in cancer development - A chemopreventive approach. Semin Cancer Biol 2021:S1044-579X(21)00194-2. [PMID: 34216789 DOI: 10.1016/j.semcancer.2021.06.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Marcos-Fernández R, Ruiz L, Blanco-Míguez A, Margolles A, Sánchez B. Precision modification of the human gut microbiota targeting surface-associated proteins. Sci Rep 2021;11:1270. [PMID: 33446697 DOI: 10.1038/s41598-020-80187-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Simin J, Tamimi RM, Engstrand L, Callens S, Brusselaers N. Antibiotic use and the risk of breast cancer: A systematic review and dose-response meta-analysis. Pharmacol Res 2020;160:105072. [PMID: 32679181 DOI: 10.1016/j.phrs.2020.105072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Yoon LS, Jacobs JP, Hoehner J, Pereira A, Gana JC, Corvalán C, Michels KB. The Association Between Breast Density and Gut Microbiota Composition at 2 Years Post-Menarche: A Cross-Sectional Study of Adolescents in Santiago, Chile. Front Cell Infect Microbiol 2021;11:794610. [PMID: 34976871 DOI: 10.3389/fcimb.2021.794610] [Reference Citation Analysis]
73 El-Mowafy M, Elgaml A, El-Mesery M, Sultan S, Ahmed TAE, Gomaa AI, Aly M, Mottawea W. Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection. Biology (Basel) 2021;10:55. [PMID: 33451143 DOI: 10.3390/biology10010055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
74 Mei S, Ma H, Chen X. Anticancer and anti-inflammatory properties of mangiferin: A review of its molecular mechanisms. Food and Chemical Toxicology 2021;149:111997. [DOI: 10.1016/j.fct.2021.111997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Nadia, Ramana J. The Human OncoBiome Database: A Database of Cancer Microbiome Datasets. CBIO 2020;15:472-7. [DOI: 10.2174/1574893614666190902152727] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
76 Plaza-Díaz J, Álvarez-Mercado AI, Ruiz-Marín CM, Reina-Pérez I, Pérez-Alonso AJ, Sánchez-Andujar MB, Torné P, Gallart-Aragón T, Sánchez-Barrón MT, Reyes Lartategui S, García F, Chueca N, Moreno-Delgado A, Torres-Martínez K, Sáez-Lara MJ, Robles-Sánchez C, Fernández MF, Fontana L. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study. BMC Cancer 2019;19:495. [PMID: 31126257 DOI: 10.1186/s12885-019-5660-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
77 Hernández-Quiroz F, Murugesan S, Velazquez-Martínez C, Villalobos-Flores LE, Maya-Lucas O, Piña-Escobedo A, García-González I, Ocadiz-Delgado R, Lambert PF, Gariglio P, García-Mena J. The vaginal and fecal microbiota of a murine cervical carcinoma model under synergistic effect of 17β-Estradiol and E7 oncogene expression. Microb Pathog 2021;152:104763. [PMID: 33529736 DOI: 10.1016/j.micpath.2021.104763] [Reference Citation Analysis]
78 Sharma VR, Singh M, Kumar V, Yadav M, Sehrawat N, Sharma DK, Sharma AK. Microbiome dysbiosis in cancer: Exploring therapeutic strategies to counter the disease. Semin Cancer Biol 2021;70:61-70. [PMID: 32693015 DOI: 10.1016/j.semcancer.2020.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
79 Jen HH, Kafeenah H, Chang TY, Lin YM, Shan YS, Wu CH, Chen SH. Quantification of the Endogenous Adduction Level on Hemoglobin and Correlation with Albumin Adduction via Proteomics: Multiple Exposure Markers of Catechol Estrogen. J Proteome Res 2021;20:4248-57. [PMID: 34406011 DOI: 10.1021/acs.jproteome.1c00097] [Reference Citation Analysis]
80 Ouyang Y, Qiu Y, Liu Y, Zhu R, Chen Y, El-Seedi HR, Chen X, Zhao C. Cancer-fighting potentials of algal polysaccharides as nutraceuticals. Food Res Int 2021;147:110522. [PMID: 34399500 DOI: 10.1016/j.foodres.2021.110522] [Reference Citation Analysis]
81 Hong J, He Y, Fu R, Si Y, Xu B, Xu J, Li X, Mao F. The relationship between night shift work and breast cancer incidence: A systematic review and meta-analysis of observational studies. Open Medicine 2022;17:712-31. [DOI: 10.1515/med-2022-0470] [Reference Citation Analysis]
82 Bose D, Banerjee S, Singh RK, Wise LM, Robertson ES. Vascular endothelial growth factor encoded by Parapoxviruses can regulate metabolism and survival of triple negative breast cancer cells. Cell Death Dis 2020;11:996. [PMID: 33219203 DOI: 10.1038/s41419-020-03203-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Han B, Jiang P, Jiang L, Li X, Ye X. Three phytosterols from sweet potato inhibit MCF7-xenograft-tumor growth through modulating gut microbiota homeostasis and SCFAs secretion. Food Res Int 2021;141:110147. [PMID: 33642013 DOI: 10.1016/j.foodres.2021.110147] [Reference Citation Analysis]
84 Zhao Y, Liu Y, Li S, Peng Z, Liu X, Chen J, Zheng X. Role of lung and gut microbiota on lung cancer pathogenesis. J Cancer Res Clin Oncol 2021;147:2177-86. [PMID: 34018055 DOI: 10.1007/s00432-021-03644-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 El Bairi K, Jabi R, Trapani D, Boutallaka H, Ouled Amar Bencheikh B, Bouziane M, Amrani M, Afqir S, Maleb A. Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut. Expert Rev Clin Pharmacol 2020;13:403-21. [PMID: 32308061 DOI: 10.1080/17512433.2020.1758063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Roberto M, Carconi C, Cerreti M, Schipilliti FM, Botticelli A, Mazzuca F, Marchetti P. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon? Front Immunol 2021;12:704942. [PMID: 34489956 DOI: 10.3389/fimmu.2021.704942] [Reference Citation Analysis]
87 Guan X, Ma F, Sun X, Li C, Li L, Liang F, Li S, Yi Z, Liu B, Xu B. Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage. Front Oncol 2020;10:902. [PMID: 32733788 DOI: 10.3389/fonc.2020.00902] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
88 Dong L, Xie J, Wang Y, Zuo D. Gut Microbiota and Immune Responses. Adv Exp Med Biol 2020;1238:165-93. [PMID: 32323185 DOI: 10.1007/978-981-15-2385-4_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
89 Rao Malla R, Marni R, Kumari S, Chakraborty A, Lalitha P. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer. Clin Breast Cancer 2021:S1526-8209(21)00260-3. [PMID: 34625387 DOI: 10.1016/j.clbc.2021.09.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
90 Kovács T, Mikó E, Ujlaki G, Sári Z, Bai P. The Microbiome as a Component of the Tumor Microenvironment. Adv Exp Med Biol 2020;1225:137-53. [PMID: 32030653 DOI: 10.1007/978-3-030-35727-6_10] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
91 Chen Q, Wang B, Wang S, Qian X, Li X, Zhao J, Zhang H, Chen W, Wang G. Modulation of the Gut Microbiota Structure with Probiotics and Isoflavone Alleviates Metabolic Disorder in Ovariectomized Mice. Nutrients 2021;13:1793. [PMID: 34070274 DOI: 10.3390/nu13061793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]